Solaron research leads to investor engagement on supply chain management

AstraZeneca plc.

ASTRAZENECA PLC.

AstraZeneca plc. is a British-Swedish pharmaceuticals company, with operations in over 100 countries. It is the world’s seventh largest pharmaceutical company.

In 2015 AstraZeneca faced questioning from investors regarding its supply chain management after evidence of irresponsible outsourcing practices was exposed.

In December 2014 Solaron’s research warned of a number ofenvironmental, social and governance risks at AstraZenenca including:

• Environmental impacts through out the supply chain in India.• Concerns of market manipulation and insider trading at AstraZeneca’s Indian unit.• Unethical clinical trials.

December 2014 Solaron research highlights environmental, social and governance risks across AstraZeneca’s Indian operations.

April 2015 An investor field study assessing AstraZeneca’s supply chain in India indicates dangerous disposal of pollution into waterways.

June 2015 Investors publicly question AstraZeneca over poor supply chain management and irresponsible outsourcing. Share price suffers significant dip.